PUBLISHER: 360iResearch | PRODUCT CODE: 1612245
PUBLISHER: 360iResearch | PRODUCT CODE: 1612245
Artificial Intelligence in Biomedical Market by Components (Hardware, Services, Software), Technology (Computer Vision, Context-Aware Computing, Machine Learning), Application, End-Users - Global Forecast 2025-2030
The Artificial Intelligence in Biomedical Market was valued at USD 4.70 billion in 2023, expected to reach USD 5.78 billion in 2024, and is projected to grow at a CAGR of 24.18%, to USD 21.40 billion by 2030.
The scope of artificial intelligence (AI) in the biomedical sector encompasses a wide range of applications from drug discovery, genomics, and medical imaging to patient monitoring and personalized medicine. AI is integral due to its ability to analyze large datasets rapidly, identify complex patterns, and predict outcomes, thereby enhancing decision-making processes and operational efficiencies. In application, AI technologies like machine learning, natural language processing, and robotic process automation are being employed to optimize clinical trials, improve diagnostic accuracy, and accelerate the drug development process. End-use sectors include healthcare providers, pharmaceutical companies, and research institutions. Market growth is chiefly driven by the increasing demand for precision medicine, technological advancements in AI, and a growing volume of healthcare data. Further, government initiatives supporting AI and the Internet of Things (IoT) integration bolster the uptake of AI in biomedical applications.
| KEY MARKET STATISTICS | |
|---|---|
| Base Year [2023] | USD 4.70 billion |
| Estimated Year [2024] | USD 5.78 billion |
| Forecast Year [2030] | USD 21.40 billion |
| CAGR (%) | 24.18% |
Key influencing growth factors include increasing healthcare expenditure, favorable regulatory environments, and collaborations between tech companies and healthcare providers. However, market expansion is challenged by concerns over data privacy, high implementation costs, and a shortage of skilled professionals in AI and biomedicine. Despite these hurdles, opportunities abound in the development of AI-powered tools for early disease detection and monitoring, which demand innovative approaches and interdisciplinary collaboration. For businesses aiming to capitalize on these opportunities, targeting AI solutions that address unmet clinical needs and collaborating with academic and research institutions may prove beneficial.
Innovation should focus on integrating AI with wearable technologies, developing comprehensive AI models for patient-specific predictions, and exploring unsupervised learning methods to handle unstructured data effectively. The nature of the market is competitive and rapidly evolving, with significant investment from both established healthcare entities and tech startups. Companies should continuously monitor regulatory changes and technological advancements to stay ahead in this dynamic environment. By fostering innovation and strategic collaboration, businesses can not only overcome present limitations but also tap into emerging opportunities for robust growth.
Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Artificial Intelligence in Biomedical Market
The Artificial Intelligence in Biomedical Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.
- Market Drivers
- Increasing digitalization and research in the biomedical sector worldwide
- Surge in drug discovery & development activities
- Rising demand for personalized and customized medicine
- Market Restraints
- High cost associated with AI in biomedical
- Market Opportunities
- Technological advancements in AI in biomedical solutions
- Favorable investment landscape for the development of AI in biomedical solutions
- Market Challenges
- Concerns associated with data privacy and security
Porter's Five Forces: A Strategic Tool for Navigating the Artificial Intelligence in Biomedical Market
Porter's five forces framework is a critical tool for understanding the competitive landscape of the Artificial Intelligence in Biomedical Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.
PESTLE Analysis: Navigating External Influences in the Artificial Intelligence in Biomedical Market
External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Artificial Intelligence in Biomedical Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.
Market Share Analysis: Understanding the Competitive Landscape in the Artificial Intelligence in Biomedical Market
A detailed market share analysis in the Artificial Intelligence in Biomedical Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.
FPNV Positioning Matrix: Evaluating Vendors' Performance in the Artificial Intelligence in Biomedical Market
The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Artificial Intelligence in Biomedical Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.
Strategy Analysis & Recommendation: Charting a Path to Success in the Artificial Intelligence in Biomedical Market
A strategic analysis of the Artificial Intelligence in Biomedical Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.
Key Company Profiles
The report delves into recent significant developments in the Artificial Intelligence in Biomedical Market, highlighting leading vendors and their innovative profiles. These include AiCure, LLC, Arterys Inc., Aspen Technology Inc, Atomwise Inc, Augmedix, Inc., Behold.ai Technologies Limited, BenevolentAI SA, BioSymetrics Inc., BPGbio Inc., Butterfly Network, Inc., Caption Health, Inc. by GE Healthcare, Cloud Pharmaceuticals, Inc., CloudMedX Inc., Corti ApS, Cyclica Inc, Deargen Inc, Deep Genomics Incorporated, Euretos Services BV, Exscientia plc, Google, LLC by Alphabet, Inc., Insilico Medicine, Intel Corporation, International Business Machines Corporation, InveniAI LLC, Isomorphic Labs, Novo Nordisk A/S, Sanofi SA, Turbine Ltd., Viseven Europe OU, and XtalPi Inc..
Market Segmentation & Coverage
This research report categorizes the Artificial Intelligence in Biomedical Market to forecast the revenues and analyze trends in each of the following sub-markets:
- Based on Components, market is studied across Hardware, Services, and Software.
- Based on Technology, market is studied across Computer Vision, Context-Aware Computing, Machine Learning, Natural Language Processing, and Querying Method.
- Based on Application, market is studied across Clinical Decision Support, Clinical Trial Coordinators & Investigators, Drug Discovery & Development, Genomics & Personalized Medicine, and Medical Imaging & Radiology.
- Based on End-Users, market is studied across Biotechnology Firms, Hospitals & Diagnostic Centers, Pharmaceutical Companies, and Research Institutions.
- Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.
The report offers a comprehensive analysis of the market, covering key focus areas:
1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.
2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.
3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.
4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.
5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.
The report also answers critical questions to aid stakeholders in making informed decisions:
1. What is the current market size, and what is the forecasted growth?
2. Which products, segments, and regions offer the best investment opportunities?
3. What are the key technology trends and regulatory influences shaping the market?
4. How do leading vendors rank in terms of market share and competitive positioning?
5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?
Table of Contents
1. Preface
- 1.1. Objectives of the Study
- 1.2. Market Segmentation & Coverage
- 1.3. Years Considered for the Study
- 1.4. Currency & Pricing
- 1.5. Language
- 1.6. Stakeholders
2. Research Methodology
- 2.1. Define: Research Objective
- 2.2. Determine: Research Design
- 2.3. Prepare: Research Instrument
- 2.4. Collect: Data Source
- 2.5. Analyze: Data Interpretation
- 2.6. Formulate: Data Verification
- 2.7. Publish: Research Report
- 2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
- 5.1. Market Dynamics
- 5.1.1. Drivers
- 5.1.1.1. Increasing digitalization and research in the biomedical sector worldwide
- 5.1.1.2. Surge in drug discovery & development activities
- 5.1.1.3. Rising demand for personalized and customized medicine
- 5.1.2. Restraints
- 5.1.2.1. High cost associated with AI in biomedical
- 5.1.3. Opportunities
- 5.1.3.1. Technological advancements in AI in biomedical solutions
- 5.1.3.2. Favorable investment landscape for the development of AI in biomedical solutions
- 5.1.4. Challenges
- 5.1.4.1. Concerns associated with data privacy and security
- 5.1.1. Drivers
- 5.2. Market Segmentation Analysis
- 5.2.1. Type: Significant penetration of AI-based biomedical software
- 5.2.2. Application: Extensive use in drug discovery & development
- 5.2.3. End-Users: Expanding applications of AI-based biomedical solutions in pharmaceutical companies
- 5.3. Porter's Five Forces Analysis
- 5.3.1. Threat of New Entrants
- 5.3.2. Threat of Substitutes
- 5.3.3. Bargaining Power of Customers
- 5.3.4. Bargaining Power of Suppliers
- 5.3.5. Industry Rivalry
- 5.4. PESTLE Analysis
- 5.4.1. Political
- 5.4.2. Economic
- 5.4.3. Social
- 5.4.4. Technological
- 5.4.5. Legal
- 5.4.6. Environmental
6. Artificial Intelligence in Biomedical Market, by Components
- 6.1. Introduction
- 6.2. Hardware
- 6.3. Services
- 6.4. Software
7. Artificial Intelligence in Biomedical Market, by Technology
- 7.1. Introduction
- 7.2. Computer Vision
- 7.3. Context-Aware Computing
- 7.4. Machine Learning
- 7.5. Natural Language Processing
- 7.6. Querying Method
8. Artificial Intelligence in Biomedical Market, by Application
- 8.1. Introduction
- 8.2. Clinical Decision Support
- 8.3. Clinical Trial Coordinators & Investigators
- 8.4. Drug Discovery & Development
- 8.5. Genomics & Personalized Medicine
- 8.6. Medical Imaging & Radiology
9. Artificial Intelligence in Biomedical Market, by End-Users
- 9.1. Introduction
- 9.2. Biotechnology Firms
- 9.3. Hospitals & Diagnostic Centers
- 9.4. Pharmaceutical Companies
- 9.5. Research Institutions
10. Americas Artificial Intelligence in Biomedical Market
- 10.1. Introduction
- 10.2. Argentina
- 10.3. Brazil
- 10.4. Canada
- 10.5. Mexico
- 10.6. United States
11. Asia-Pacific Artificial Intelligence in Biomedical Market
- 11.1. Introduction
- 11.2. Australia
- 11.3. China
- 11.4. India
- 11.5. Indonesia
- 11.6. Japan
- 11.7. Malaysia
- 11.8. Philippines
- 11.9. Singapore
- 11.10. South Korea
- 11.11. Taiwan
- 11.12. Thailand
- 11.13. Vietnam
12. Europe, Middle East & Africa Artificial Intelligence in Biomedical Market
- 12.1. Introduction
- 12.2. Denmark
- 12.3. Egypt
- 12.4. Finland
- 12.5. France
- 12.6. Germany
- 12.7. Israel
- 12.8. Italy
- 12.9. Netherlands
- 12.10. Nigeria
- 12.11. Norway
- 12.12. Poland
- 12.13. Qatar
- 12.14. Russia
- 12.15. Saudi Arabia
- 12.16. South Africa
- 12.17. Spain
- 12.18. Sweden
- 12.19. Switzerland
- 12.20. Turkey
- 12.21. United Arab Emirates
- 12.22. United Kingdom
13. Competitive Landscape
- 13.1. Market Share Analysis, 2023
- 13.2. FPNV Positioning Matrix, 2023
- 13.3. Competitive Scenario Analysis
- 13.3.1. Bionl.AI Launches Innovative Platform for No-Code Biomedical Research
- 13.3.2. Epistemic AI launches biomedical GPT at BIO
- 13.3.3. NIH launches Bridge2AI program to expand the use of artificial intelligence in biomedical and behavioral research
- 13.4. Strategy Analysis & Recommendation
Companies Mentioned
- 1. AiCure, LLC
- 2. Arterys Inc.
- 3. Aspen Technology Inc
- 4. Atomwise Inc
- 5. Augmedix, Inc.
- 6. Behold.ai Technologies Limited
- 7. BenevolentAI SA
- 8. BioSymetrics Inc.
- 9. BPGbio Inc.
- 10. Butterfly Network, Inc.
- 11. Caption Health, Inc. by GE Healthcare
- 12. Cloud Pharmaceuticals, Inc.
- 13. CloudMedX Inc.
- 14. Corti ApS
- 15. Cyclica Inc
- 16. Deargen Inc
- 17. Deep Genomics Incorporated
- 18. Euretos Services BV
- 19. Exscientia plc
- 20. Google, LLC by Alphabet, Inc.
- 21. Insilico Medicine
- 22. Intel Corporation
- 23. International Business Machines Corporation
- 24. InveniAI LLC
- 25. Isomorphic Labs
- 26. Novo Nordisk A/S
- 27. Sanofi SA
- 28. Turbine Ltd.
- 29. Viseven Europe OU
- 30. XtalPi Inc.
LIST OF FIGURES
- FIGURE 1. ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET RESEARCH PROCESS
- FIGURE 2. ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, 2023 VS 2030
- FIGURE 3. GLOBAL ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, 2018-2030 (USD MILLION)
- FIGURE 4. GLOBAL ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 5. GLOBAL ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 6. GLOBAL ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY COMPONENTS, 2023 VS 2030 (%)
- FIGURE 7. GLOBAL ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY COMPONENTS, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 8. GLOBAL ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
- FIGURE 9. GLOBAL ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 10. GLOBAL ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
- FIGURE 11. GLOBAL ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 12. GLOBAL ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY END-USERS, 2023 VS 2030 (%)
- FIGURE 13. GLOBAL ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY END-USERS, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 14. AMERICAS ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 15. AMERICAS ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 16. UNITED STATES ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY STATE, 2023 VS 2030 (%)
- FIGURE 17. UNITED STATES ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 18. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 19. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 20. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 21. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 22. ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SHARE, BY KEY PLAYER, 2023
- FIGURE 23. ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET, FPNV POSITIONING MATRIX, 2023
LIST OF TABLES
- TABLE 1. ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SEGMENTATION & COVERAGE
- TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
- TABLE 3. GLOBAL ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, 2018-2030 (USD MILLION)
- TABLE 4. GLOBAL ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
- TABLE 5. GLOBAL ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
- TABLE 6. ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET DYNAMICS
- TABLE 7. GLOBAL ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
- TABLE 8. GLOBAL ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY HARDWARE, BY REGION, 2018-2030 (USD MILLION)
- TABLE 9. GLOBAL ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY SERVICES, BY REGION, 2018-2030 (USD MILLION)
- TABLE 10. GLOBAL ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2030 (USD MILLION)
- TABLE 11. GLOBAL ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
- TABLE 12. GLOBAL ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY COMPUTER VISION, BY REGION, 2018-2030 (USD MILLION)
- TABLE 13. GLOBAL ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY CONTEXT-AWARE COMPUTING, BY REGION, 2018-2030 (USD MILLION)
- TABLE 14. GLOBAL ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY MACHINE LEARNING, BY REGION, 2018-2030 (USD MILLION)
- TABLE 15. GLOBAL ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY NATURAL LANGUAGE PROCESSING, BY REGION, 2018-2030 (USD MILLION)
- TABLE 16. GLOBAL ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY QUERYING METHOD, BY REGION, 2018-2030 (USD MILLION)
- TABLE 17. GLOBAL ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 18. GLOBAL ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY CLINICAL DECISION SUPPORT, BY REGION, 2018-2030 (USD MILLION)
- TABLE 19. GLOBAL ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY CLINICAL TRIAL COORDINATORS & INVESTIGATORS, BY REGION, 2018-2030 (USD MILLION)
- TABLE 20. GLOBAL ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
- TABLE 21. GLOBAL ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY GENOMICS & PERSONALIZED MEDICINE, BY REGION, 2018-2030 (USD MILLION)
- TABLE 22. GLOBAL ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY MEDICAL IMAGING & RADIOLOGY, BY REGION, 2018-2030 (USD MILLION)
- TABLE 23. GLOBAL ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
- TABLE 24. GLOBAL ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY BIOTECHNOLOGY FIRMS, BY REGION, 2018-2030 (USD MILLION)
- TABLE 25. GLOBAL ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY HOSPITALS & DIAGNOSTIC CENTERS, BY REGION, 2018-2030 (USD MILLION)
- TABLE 26. GLOBAL ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
- TABLE 27. GLOBAL ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY RESEARCH INSTITUTIONS, BY REGION, 2018-2030 (USD MILLION)
- TABLE 28. AMERICAS ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
- TABLE 29. AMERICAS ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
- TABLE 30. AMERICAS ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 31. AMERICAS ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
- TABLE 32. AMERICAS ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
- TABLE 33. ARGENTINA ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
- TABLE 34. ARGENTINA ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
- TABLE 35. ARGENTINA ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 36. ARGENTINA ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
- TABLE 37. BRAZIL ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
- TABLE 38. BRAZIL ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
- TABLE 39. BRAZIL ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 40. BRAZIL ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
- TABLE 41. CANADA ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
- TABLE 42. CANADA ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
- TABLE 43. CANADA ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 44. CANADA ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
- TABLE 45. MEXICO ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
- TABLE 46. MEXICO ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
- TABLE 47. MEXICO ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 48. MEXICO ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
- TABLE 49. UNITED STATES ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
- TABLE 50. UNITED STATES ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
- TABLE 51. UNITED STATES ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 52. UNITED STATES ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
- TABLE 53. UNITED STATES ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
- TABLE 54. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
- TABLE 55. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
- TABLE 56. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 57. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
- TABLE 58. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
- TABLE 59. AUSTRALIA ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
- TABLE 60. AUSTRALIA ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
- TABLE 61. AUSTRALIA ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 62. AUSTRALIA ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
- TABLE 63. CHINA ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
- TABLE 64. CHINA ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
- TABLE 65. CHINA ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 66. CHINA ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
- TABLE 67. INDIA ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
- TABLE 68. INDIA ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
- TABLE 69. INDIA ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 70. INDIA ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
- TABLE 71. INDONESIA ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
- TABLE 72. INDONESIA ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
- TABLE 73. INDONESIA ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 74. INDONESIA ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
- TABLE 75. JAPAN ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
- TABLE 76. JAPAN ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
- TABLE 77. JAPAN ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 78. JAPAN ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
- TABLE 79. MALAYSIA ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
- TABLE 80. MALAYSIA ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
- TABLE 81. MALAYSIA ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 82. MALAYSIA ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
- TABLE 83. PHILIPPINES ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
- TABLE 84. PHILIPPINES ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
- TABLE 85. PHILIPPINES ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 86. PHILIPPINES ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
- TABLE 87. SINGAPORE ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
- TABLE 88. SINGAPORE ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
- TABLE 89. SINGAPORE ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 90. SINGAPORE ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
- TABLE 91. SOUTH KOREA ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
- TABLE 92. SOUTH KOREA ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
- TABLE 93. SOUTH KOREA ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 94. SOUTH KOREA ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
- TABLE 95. TAIWAN ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
- TABLE 96. TAIWAN ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
- TABLE 97. TAIWAN ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 98. TAIWAN ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
- TABLE 99. THAILAND ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
- TABLE 100. THAILAND ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
- TABLE 101. THAILAND ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 102. THAILAND ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
- TABLE 103. VIETNAM ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
- TABLE 104. VIETNAM ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
- TABLE 105. VIETNAM ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 106. VIETNAM ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
- TABLE 107. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
- TABLE 108. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
- TABLE 109. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 110. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
- TABLE 111. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
- TABLE 112. DENMARK ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
- TABLE 113. DENMARK ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
- TABLE 114. DENMARK ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 115. DENMARK ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
- TABLE 116. EGYPT ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
- TABLE 117. EGYPT ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
- TABLE 118. EGYPT ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 119. EGYPT ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
- TABLE 120. FINLAND ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
- TABLE 121. FINLAND ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
- TABLE 122. FINLAND ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 123. FINLAND ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
- TABLE 124. FRANCE ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
- TABLE 125. FRANCE ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
- TABLE 126. FRANCE ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 127. FRANCE ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
- TABLE 128. GERMANY ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
- TABLE 129. GERMANY ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
- TABLE 130. GERMANY ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 131. GERMANY ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
- TABLE 132. ISRAEL ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
- TABLE 133. ISRAEL ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
- TABLE 134. ISRAEL ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 135. ISRAEL ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
- TABLE 136. ITALY ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
- TABLE 137. ITALY ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
- TABLE 138. ITALY ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 139. ITALY ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
- TABLE 140. NETHERLANDS ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
- TABLE 141. NETHERLANDS ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
- TABLE 142. NETHERLANDS ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 143. NETHERLANDS ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
- TABLE 144. NIGERIA ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
- TABLE 145. NIGERIA ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
- TABLE 146. NIGERIA ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 147. NIGERIA ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
- TABLE 148. NORWAY ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
- TABLE 149. NORWAY ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
- TABLE 150. NORWAY ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 151. NORWAY ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
- TABLE 152. POLAND ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
- TABLE 153. POLAND ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
- TABLE 154. POLAND ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 155. POLAND ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
- TABLE 156. QATAR ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
- TABLE 157. QATAR ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
- TABLE 158. QATAR ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 159. QATAR ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
- TABLE 160. RUSSIA ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
- TABLE 161. RUSSIA ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
- TABLE 162. RUSSIA ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 163. RUSSIA ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
- TABLE 164. SAUDI ARABIA ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
- TABLE 165. SAUDI ARABIA ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
- TABLE 166. SAUDI ARABIA ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 167. SAUDI ARABIA ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
- TABLE 168. SOUTH AFRICA ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
- TABLE 169. SOUTH AFRICA ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
- TABLE 170. SOUTH AFRICA ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 171. SOUTH AFRICA ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
- TABLE 172. SPAIN ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
- TABLE 173. SPAIN ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
- TABLE 174. SPAIN ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 175. SPAIN ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
- TABLE 176. SWEDEN ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
- TABLE 177. SWEDEN ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
- TABLE 178. SWEDEN ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 179. SWEDEN ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
- TABLE 180. SWITZERLAND ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
- TABLE 181. SWITZERLAND ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
- TABLE 182. SWITZERLAND ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 183. SWITZERLAND ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
- TABLE 184. TURKEY ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
- TABLE 185. TURKEY ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
- TABLE 186. TURKEY ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 187. TURKEY ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
- TABLE 188. UNITED ARAB EMIRATES ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
- TABLE 189. UNITED ARAB EMIRATES ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
- TABLE 190. UNITED ARAB EMIRATES ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 191. UNITED ARAB EMIRATES ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
- TABLE 192. UNITED KINGDOM ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
- TABLE 193. UNITED KINGDOM ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
- TABLE 194. UNITED KINGDOM ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 195. UNITED KINGDOM ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
- TABLE 196. ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SHARE, BY KEY PLAYER, 2023
- TABLE 197. ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET, FPNV POSITIONING MATRIX, 2023
